Code
|
4160B
|
MA number
|
16/0167/15-S
|
Product Form:
|
plv iol 1x1500 IU+1x3 ml solv. (liek.inj.skl.+liek.inj.skl.)
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
Type of procedure:
|
Decentralised
|
MAH, country:
|
CSL Behring GmbH, Germany
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
ATC:
|
B |
BLOOD AND BLOOD FORMING ORGANS |
B06 |
OTHER HEMATOLOGICAL AGENTS |
B06A |
OTHER HEMATOLOGICAL AGENTS |
B06AC |
Drugs used in hereditary angioedema |
B06AC01 |
C1-inhibitor, plasma derived |
|
Shelf life:
|
36 |
Container:
|
glass vial
|
Route of admin.:
|
Intravenous use
|